Lower-field visual barrier
An opaque lower region and conformable interface are designed to limit visibility of activity occurring below eye level.
Akoya Eye Shield
A focused visual barrier for needle-based care.
Designed to limit a patient's direct view of procedural activity below eye level while leaving an upper viewing area open for partial forward and upward awareness.
Single-patient use
Nonsterile
Latex-free
Assembled in the USA
Founder-ledDirect access to Akoya's founder and product team.
Issued U.S. patentU.S. Patent No. 12,629,282 B1, issued May 19, 2026.
Healthcare-focusedDeveloped around selected vascular-access and interventional workflows.
Available by quoteFlexible quantities, product samples, and institutional discussions.
What the design does
Limits the procedural view. Preserves an open upper view.
Akoya Eye Shield addresses one narrow source of discomfort: direct visual exposure to needles and procedural activity. Actual visual obstruction depends on fit, positioning, facial anatomy, and gaze direction.
Open upper viewing area
The upper area remains open, allowing partial forward or upward visibility for awareness and communication.
Akoya Eye Shield
A simple, physical approach to visual exposure.
- Single-patient use and not intended for reuse
- Nonsterile and latex-free
- Assembled in the USA
- Adjustable frame with a conformable lower interface
- Available now in quantities aligned with organizational needs
Early patient-reported feedback
An encouraging starting point—not a clinical effectiveness study.
45Completed questionnaires
50Patients offered feedback
Initial descriptive feedback was collected in a breast-biopsy setting. It was not a randomized or controlled clinical study and does not establish clinical effectiveness or predict results in infusion care.
Patent verification
Lower-field vision-obstruction technology described in an issued U.S. patent.
The technology and method described in U.S. Patent No. 12,629,282 B1 use an opaque lower region and a conformable interface to limit lower-field visibility while preserving partial forward or upward visibility. A patent documents intellectual property; it does not establish clinical effectiveness or regulatory clearance.
View the public patent recordPatentU.S. 12,629,282 B1
IssuedMay 19, 2026
TitleMethod and Eyewear Apparatus for Lower Visual Field Obstruction
InventorsDrew Richard Zaun and Thomas Raymond Goetz
Considering Akoya for a clinical setting?
Start with product samples, a brief staff demonstration, or a limited one-site evaluation.